APP Pharmaceuticals Inc. (APPX) is in the Pharma Industry

• Sort by
• View by Content Type

• Best and Worst Performing Stocks of the Current Bear Market

  Hickey and Walters Bespoke submit: Since the current bear market began back on October 9th, 2007, the Russell 1,000 is down about 18%.  Of the stocks in the index, 8.5% are down more than 50%, while 25% are actually up since then.  Below we highlight the 25 best...

  External links 2008-08-25

  Tags: US Market, Financial, Arch Coal Inc., American International Group Inc., Alpha Natural Resources Inc., APP Pharmaceuticals Inc., Bucyrus International Inc., Boyd Gaming Corp., Avis Budget Group Inc., CF Industries Holdings Inc., CIT Group, Cleveland-Cliffs Inc., Continental Resources Inc., Encore Acquisition Co., E*Trade Financial Corp., Flowserve Corp., Fannie Mae, Freddie Mac, First Solar Inc., General Motors Corp., Hess Corp., Petrohawk Energy Corp., Helmerich & Payne Inc., Illumina Inc., Kansas City Southern, Lehman Brothers Holdings Inc., Las Vegas Sands Corp., MasterCard Inc., MBIA Inc., Massey Energy Co., Mosaic Co., MGIC Investment Corp., National City Corp., Office Depot Inc., Oshkosh Truck Corp., Perrigo Co., Rite Aid Corp., Regions Financial Corp., iStar Financial Inc., SLM Corp., SanDisk Corp., Sohu.com, Southwestern Energy Co., Tenet Healthcare Corp., Terra Industries Inc., Tesoro Corp., Wachovia Corp., Whiting Petroleum Corp., Walter Industries Inc., Washington Mutual Inc.

• APP Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript

  APP Pharmaceuticals, Inc. APPX Q2 2008 Earnings Call Transcript

  Earnings calls 2008-08-24

  Tags: Call Transcript, Earnings, Seeking Alpha, APP Pharmaceuticals Inc.

• Merger Watch: APP Pharmaceuticals - Fresenius

  The M & A Researcher submits: APP Pharmaceuticals, Inc. APPX filed the definitive proxy statement for its merger with Fresenius with the SEC on Wednesday (August 20). There are no material updates to the pending HSR review process, nor any specific closing or target closing dates disclosed in...

  External links 2008-08-22

  Tags: Healthcare, APP Pharmaceuticals Inc.

• APP Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript

  APP Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript

  Earnings calls 2008-05-13

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, APP Pharmaceuticals Inc.

Additional Resources

• APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission

  SCHAUMBURG, Ill. & BAD HOMBURG V.D.H., Germany -- APP Pharmaceuticals, Inc. (Nasdaq:APPX) and Fresenius SE (XETRA:FRE) have received confirmation that the U.S. Federal Trade Commission FTC has completed its review of the proposed acquisition of APP Pharmaceuticals by Fresenius Kabi, a business segment of Fresenius SE. The FTC granted early...

  Articles 2008-09-02

• APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility

  Approvals Significantly Expand Manufacturing Capacity for Heparin SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq: APPX), a leading provider of hospital-based injectable pharmaceutical products, today said that the U.S Food and Drug Administration FDA has approved APP's manufacturing facility in Barceloneta, Puerto Rico for the manufacture of three product...

  Articles 2008-08-18

• APP Pharmaceuticals Reports 2008 Second Quarter Net Revenues of $198 Million, Operating Income of $53 Million

  Second Quarter Net Revenues Increased 24 Percent, Income from Operations Grew 31 Percent SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today reported financial results for the second quarter and six months ended June 30, 2008. As a result...

  Articles 2008-08-01

• APP Pharmaceuticals Announces Date for 2008 Second Quarter Financial Results and Investor Conference Call

  SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced it will release its 2008 second quarter financial results after the market closes on Thursday, July 31, 2008. The Company also said that senior management will host an investor conference call...

  Articles 2008-07-24

• Market Pulse Breaking News Alert for Tuesday, July 8, 2008: PRRY -- Planet Resource Recovery Receives Significant Purchase Orders to Treat 26 Oil Wells With PetroLuxus(TM) Products in US!

  Market Pulse News Alert for this AM, Stocks toWatch are: Planet Resource Recovery, Inc. (PINKSHEETS: PRRY), UniversalEnergy Corp. (OTCBB: UVSE), Yahoo! Inc. (NASDAQ: YHOO) and APPPharmaceuticals Inc. (NASDAQ: APPX). Investors need to be watching Planet Resource Recovery, Inc. (PINKSHEETS: PRRY) this AM! Planet Resource Recovery is the developer...

  Articles 2008-07-08

• ONN Sidewinder Video Report: Unusual Activity with Yahoo Options

  The Monday, July 7, 2008 Sidewinder Video Report CHICAGO -- The Sidewinder Report, the www.onn.tv daily options news program recorded live on the floor of the Chicago Board Options Exchange, today examined options trading in the following securities: Juniper Networks Inc JNPR ...

  Articles 2008-07-07

• APP Pharmaceuticals to Be Acquired by Fresenius

  Combination Expands Leadership Position in Injectable Hospital Based Markets SCHAUMBURG, Ill. & BAD HOMBURG v.d.H., Germany -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading provider of hospital-based injectable pharmaceutical products, and Fresenius SE (XETRA:FRE), a global health care group with approximately $18 billion of sales in...

  Articles 2008-07-07

• APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP

  Company Now Markets Full Line SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S. Food and Drug Administration FDA of its Abbreviated New Drug Applications ANDAs...

  Articles 2008-07-03

• Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes

  NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...

  Articles 2008-06-17

• APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP

  - New Labeling to Further Assist Clinicians in Averting Medical Errors with "High-Alert" Medication - SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX) today announced the launch of enhanced labeling for its line of Heparin Sodium Injection, USP. The labels and cap colors for APP's heparin have incorporated clearly...

  Articles 2008-06-02

• Navigating A Political Minefield

  Patrick Soon-Shiong is steeringAPP Pharmaceuticals of Schaumburg, Ill. through some extremely choppy political waters of late. As a medical doctor and researcher by training, Soon-Shiong, APP's chairman, is focused as much on the science behind the drugs as he is on the financials. Revenue rose 11% in 2007...

  Articles 2008-06-01

• APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply

  SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq: APPX) is communicating in a letter to its customers that the company continues to work closely with the U.S. Food and Drug Administration FDA to ensure that an uninterrupted and safe supply of heparin of the highest quality is available for U.S. patients....

  Articles 2008-05-15

• Price of blood thinner has doubled since recall

  Major U.S. dialysis centers say the price of blood-thinner heparin has doubled since mid-April because of global recalls and tight supplies since the discovery of contaminated raw product from China. At Renal Advantage's 90 dialysis centers, prices have gone up twice since mid-April, says Angela Newman, vice president....

  Articles 2008-05-09

• APP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 Million

  * Reports 11% Increase in Income from Operations Before Interest Expense to $32.5 Million * Receives Four New Product Approvals from FDA in the 2008 First Quarter SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today reported...

  Articles 2008-05-08

• APP Pharmaceuticals Announces Date for 2008 First Quarter Financial Results and Investor Conference Call

  SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced it will release its 2008 first quarter financial results before the market opens on Thursday, May 8, 2008. The Company also said that senior management will host an investor conference call...

  Articles 2008-05-01

• APP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial Officer

  SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that Thomas H. Silberg has been promoted to president and chief executive officer, succeeding Patrick Soon-Shoing, M.D., who will remain as chairman of the board. The company also announced that Richard...

  Articles 2008-05-01